From the start, Bluelight has attracted academic researchers who are interested
in understanding drug use practices and patterns. We have many academic researchers
that participate in our community as forum members and some who are on staff.
Our Drug Studies
forum has been going since 2007 and has supported many hundreds of important
research projects. The Bluelight research portal is our appeal to academic researchers
to consider engaging with Bluelight to assist them with their research.
What we want to do is to continue to support open dialogue between researchers and our community. We believe this is a win-win situation for both parties: researchers get to recruit participants and get critical feedback on their studies, while our community gets to contribute to and access research results, and both get the chance to talk openly through the Bluelight forums.
While it is true that not all researchers play by these rules, we have had mostly successes, and we believe that as we build our connections with the research community, we will be better able to develop constructive, two-way dialogues that enrich both parties.
We have also been able to fund large parts of the running costs of Bluelight through the generous donations of researchers whom we assist. Without their support, our site may not exist at all, or at least not in the familiar, user-friendly form it's taken today. We thus hope to attract further researchers willing to donate so that we may become more self-sufficient and sustainable, and more confident about paying our bills while keeping the forums free of advertisements.
Our pledge to the Bluelight community is that despite those research links:
Whether you choose to participate in a research project endorsed
by Bluelight is always your decision. But you can trust that if
the study is supported by us, we have checked it out and it is
legitimate. If you still have concerns about researcher legitimacy
or integrity, please contact the Drug Studies moderator team
or any senior
staff member or administrator.
We appreciate your support of Bluelight's research portal and invite any discussion in this thread.